Asgard Therapeutics Secures €30M in Series A Funding
TLDR: Asgard Therapeutics Raises €30M in Series A Financing Asgard Therapeutics, a biotech company in Sweden, raised €30M in Series A funding for cancer immunotherapy. The funding will support the development of